… adopted for the delivery of siRNA/miRNA combinations with other anticancer agents (…
with siRNA or miRNA significantly enhances the sensitivity of chemotherapeutic drugs by …

… In this post-genomic era, microRNAs (miRNAs) are receiving … of miRNAs and chemotherapeutic
agents for cancer treatment. Moreover, we attempted to portray the role of miRNAs in …

… of chemotherapy and RNAi technology holds great promise as a new strategy for cancer
treatment. However, the chemotherapeutic agents and siRNAs … rather than miRNA and piRNA […

… chemotherapeutic agent could be delivered along with oligonucleotide/s (siRNA/miRNA)
to … Thus gene-based therapeutics in combination with potent chemotherapeutic agents is a …

… using siRNA, and hence the design of novel drugs, ie, cancer drugs in combination with
siRNA, … Nanoparticle platforms incorporating miRNA and chemotherapeutic drugs have been …

… , in which chemotherapy enhances intratumoral siRNA delivery and the delivered siRNA …
Combination of siRNA-containing nanocarriers with chemotherapy may compensate for the …

… miRNA (Micro RNA) miRNAs are single-stranded, non-coding RNA oligonucleotides (20–25
base pairs). Multiple siRNAs can be created from a single miRNA transcript. They target …

… Dicer in complex with different siRNA were solved [124]. A visual analysis of these structures
confirmed that the 2 nucleotide overhangs at the 3’ end of the siRNA are located in the PAZ …

… siRNA and miRNA can selectively knock down the carcinogenic genes by targeting specific
mRNAs. Therefore, combining chemotherapeutic drugs with gene agents … agents and drugs, …

… of siRNA in suppressing cisplatin (CP) resistance in cancer. CP is a well-known chemotherapeutic
agent… factors including p15, p21, p27 and miRNA-218, while it reduces expressions of …